SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-019423
Filing Date
2017-03-27
Accepted
2017-03-27 17:11:22
Documents
4
Effectiveness Date
2017-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 a17-9122_2s8.htm S-8 121978
2 EX-5.1 a17-9122_2ex5d1.htm EX-5.1 9929
3 EX-23.1 a17-9122_2ex23d1.htm EX-23.1 3193
4 GRAPHIC g91222kii001.jpg GRAPHIC 2234
  Complete submission text file 0001104659-17-019423.txt   139445
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216967 | Film No.: 17716074
SIC: 2834 Pharmaceutical Preparations